A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes
The bioavailability of a monoclonal antibody (mAb) or another therapeutic protein after subcutaneous (SC) dosing is challenging to predict from first principles, even if the impact of injection site physiology and drug properties on mAb bioavailability is generally understood. We used a physiologica...
| 发表在: | Antibodies |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | 文件 |
| 语言: | 英语 |
| 出版: |
MDPI AG
2024-08-01
|
| 主题: | |
| 在线阅读: | https://www.mdpi.com/2073-4468/13/3/70 |
